Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism AMPK agonists(AMP activated protein kinase agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization NephroDI Therapeutics, Inc.Startup |
Active Organization NephroDI Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationRare Pediatric Disease (US), Orphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Insipidus, Nephrogenic | Preclinical | US | NephroDI Therapeutics, Inc.Startup | 20 Jun 2024 |